This product is a Raji-Luc2 B cell engineering tool based on the Nanoparticles (Fucoidan/P-selectin) delivery system and CRISPR-based (hROSA26-sgRNA-Cpf1-SCR7 pyrazine ) genome editor.
| Host Cell | Raji-Luc2 |
| Target | CD163 |
| Insert Clone | BCRYA-0147 |
| Safe Harbor Sites (SHS) | hROSA26 |
| gRNA | sgRNA |
| Nuclease | Cpf1 |
| Enhancer | SCR7 pyrazine |
| Targeting Strategy | pH responsive, mucoadhesiveness |
| Insertion sites | Large DNA sequences |
| Vehicles | Nanoparticles |
| Ligand/Receptor | Fucoidan/P-selectin |
| Active Agents | Talazoparib, temozolomide |
| Particle Size | <1000 |
| Charge (mv) | −25 to -125 |
| Total Atom Count | ~65,000,000 |
| Surface Atoms (%) | ~0.6 |
| Specific Surface Area (m2/g) | ~0.8 |
| Vector Type | RABV |
| Vector Name | BCpCDH8 |
| Targeting Diseases | Breast cancer; Colon cancer; Glioblastoma; Gastric cancer; Liver cancer |
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.